Literature DB >> 31625269

The Machado-Joseph disease deubiquitylase ataxin-3 interacts with LC3C/GABARAP and promotes autophagy.

Laura K Herzog1, Éva Kevei2, Ricardo Marchante2, Claudia Böttcher1, Christian Bindesbøll3, Alf Håkon Lystad3, Annika Pfeiffer1, Maria E Gierisch1, Florian A Salomons1, Anne Simonsen3, Thorsten Hoppe2, Nico P Dantuma1.   

Abstract

The pathology of spinocerebellar ataxia type 3, also known as Machado-Joseph disease, is triggered by aggregation of toxic ataxin-3 (ATXN3) variants containing expanded polyglutamine repeats. The physiological role of this deubiquitylase, however, remains largely unclear. Our recent work showed that ATX-3, the nematode orthologue of ATXN3, together with the ubiquitin-directed segregase CDC-48, regulates longevity in Caenorhabditis elegans. Here, we demonstrate that the long-lived cdc-48.1; atx-3 double mutant displays reduced viability under prolonged starvation conditions that can be attributed to the loss of catalytically active ATX-3. Reducing the levels of the autophagy protein BEC-1 sensitized worms to the effect of ATX-3 deficiency, suggesting a role of ATX-3 in autophagy. In support of this conclusion, the depletion of ATXN3 in human cells caused a reduction in autophagosomal degradation of proteins. Surprisingly, reduced degradation in ATXN3-depleted cells coincided with an increase in the number of autophagosomes while levels of lipidated LC3 remained unaffected. We identified two conserved LIR domains in the catalytic Josephin domain of ATXN3 that directly interacted with the autophagy adaptors LC3C and GABARAP in vitro. While ATXN3 localized to early autophagosomes, it was not subject to lysosomal degradation, suggesting a transient regulatory interaction early in the autophagic pathway. We propose that the deubiquitylase ATX-3/ATXN3 stimulates autophagic degradation by preventing superfluous initiation of autophagosomes, thereby promoting an efficient autophagic flux important to survive starvation.
© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Caenorhabditis eleganszzm321990; zzm321990atx-3zzm321990; DUB; ataxin-3; autophagy; ubiquitin

Year:  2019        PMID: 31625269      PMCID: PMC6974715          DOI: 10.1111/acel.13051

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


INTRODUCTION

Ataxin‐3 (ATXN3), which is the founding member of the family of Josephin domain‐containing deubiquitylases (DUBs), plays a critical role in the maintenance of protein homeostasis and stress resistance (Burnett & Pittman, 2005; Durcan et al., 2011; Scaglione et al., 2011; Wang, Li, & Ye, 2006; Zhong & Pittman, 2006). Abnormal expansion of a stretch of glutamine residues in the C‐terminus of ATXN3 is causative for spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease, the most common hereditary type of ataxia (Kawaguchi et al., 1994). While mutant ATXN3 causes neuronal demise through a predominant, toxic gain‐of‐function mechanism typically associated with polyglutamine (polyQ) disorders, wild‐type ATXN3 has neuroprotective properties and can reduce the toxicity caused by polyglutamine proteins in cellular and Drosophila models (Tsou et al., 2015; Warrick et al., 2005). Hence, a loss of its protective function may contribute to the disease, consistent with a general role of ATXN3 in maintaining protein homeostasis. Interestingly, simultaneous inactivation of ATX‐3, and the ubiquitin‐selective segregase CDC‐48.1 in the nematode Caenorhabditis elegans (Olszewski, Williams, Dong, & Martin, 2019), results in extended lifespan (Kuhlbrodt et al., 2011). This synergistic effect on the longevity of cdc‐48.1; atx‐3 double mutants depends on the insulin/insulin‐like growth factor‐1 signaling (IIS) pathway (Kuhlbrodt et al., 2011). Aging is typically accompanied by a gradual decline in the functionality of autophagy, and conversely, genetic or dietary stimulation of autophagy promotes longevity in various model organisms (Leidal, Levine, & Debnath, 2018). Hence, there appears to be a positive correlation between lifespan and the functionality of autophagy, which is also triggered by IIS (Melendez et al., 2003). Another emerging theme is the involvement of proteins linked to age‐related neurodegenerative disorders in the autophagic degradation of aberrant proteins and organelles (Menzies, Fleming, & Rubinsztein, 2015). Dysfunction of neurodegeneration‐associated proteins involved in autophagy may lead to impaired autophagy, which has been proposed to contribute to the pathophysiology in various neurodegenerative disorders (Ashkenazi et al., 2017; Ju et al., 2009; Martinez‐Vicente et al., 2010; Rui et al., 2015; Tresse et al., 2010). Thus, ATX‐3/ATXN3 is linked to both longevity and neurodegenerative disorders, which are associated with increased and impaired autophagy, respectively. Autophagy can be triggered by a variety of stressors, such as the presence of cytotoxic protein aggregates, to ensure cell survival, while also regulating nutrient recycling during periods of nutrient deprivation. The initiation, formation, and elongation of the autophagosomal membrane is regulated by phosphatidylethanolamine (PE) conjugation and autophagosomal anchoring of six highly related ubiquitin‐like modifiers belonging to the Atg8 family: LC3A, LC3B, LC3C, GABARAP, GABARAPL1, and GABARAPL2. LC3s and GABARAPs play critical roles in facilitating the recruitment of cargo receptors and other autophagy proteins to autophagosomes by directly interacting with these proteins through conserved LC3‐interacting regions (LIRs) (Johansen & Lamark, 2011). After fusion with lysosomes, the fraction of LC3/GABARAP localized on the luminal side of autophagic vesicles is degraded in the lysosomes together with cargo receptors and substrates, while LC3/GABARAP present on the cytosolic face is released by Atg4 protease (Abreu et al., 2017). Despite the well‐established involvement of ubiquitin ligases in autophagy, the role of DUBs in this process has only recently gained interest (Clague & Urbe, 2017). Beclin‐1 has been shown to be a prominent substrate of various DUBs, including USP10, USP13 (Liu et al., 2011), USP9X (Elgendy et al., 2014), and ATXN3 (Ashkenazi et al., 2017). As a core component of the class III PI3‐kinase/Vps34 complex, beclin‐1 supports the induction of autophagy by stimulation of Vps34‐dependent generation of phosphatidylinositol‐3‐phosphate. Stabilization of beclin‐1 by ATXN3 has been proposed to promote lipidation of LC3 and autophagy (Ashkenazi et al., 2017). Here, we show that the long‐lived cdc‐48.1; atx‐3 double mutant displays increased sensitivity to nutrient starvation and impaired ability to clear aggregation‐prone proteins, two phenotypes that are indicative for defective autophagy. In agreement with a new physiological role of ATXN3 in autophagy, we show that ATXN3 is an LC3C/GABARAP‐interacting DUB that regulates the formation of autophagosomes independent from its stabilizing effect on beclin‐1 (Ashkenazi et al., 2017). Our study implicates a conserved regulatory role for ATX‐3/ATXN3 in autophagy and shows that increased lifespan can come at the expense of a reduced ability to maintain organismal protein homeostasis under stress conditions, such as starvation.

RESULTS

Autophagy is impaired in ATX‐3‐deficient worms

Given the correlation between lifespan and autophagy, we explored the functional status of autophagy in long‐lived cdc‐48.1; atx‐3 double mutant worms. To this end, we examined the survival of starved L1 larvae, a metabolic challenge that strongly depends on functional autophagy (Kovacs & Zhang, 2010). When worms hatch in the absence of food, larvae arrest at the L1 diapause and can survive for several weeks, from which they recover and resume growth upon refeeding. We found that the cdc‐48.1; atx‐3 deletion mutant had a significantly decreased recovery rate and reduced viability in comparison with wild‐type worms, indicative of a defect in the autophagy–lysosome pathway (Figure 1a, Table S1). ATXN3 and p97 (also known as valosin‐containing protein (VCP)), which are the human orthologues of ATX‐3 and CDC‐48, respectively, have both been implicated in autophagy (Ashkenazi et al., 2017; Ju et al., 2009; Tresse et al., 2010). To clarify to what extent the increased sensitivity could be attributed to ATX‐3 or CDC‐48, we next evaluated the survival of atx‐3 or cdc‐48.1 single‐deletion strains. While the deletion of CDC‐48 did not increase the sensitivity of larvae to starvation (Figure 1a, Table S1), the two independent atx‐3 deletion alleles tm1689 and gk193 phenocopied the starvation sensitivity of the cdc‐48.1; atx‐3 double mutant (Figure 1b, Table S2). Importantly, the decreased survival of ATX‐3‐deficient worms upon starvation could be rescued by reintroduction of GFP‐tagged wild‐type ATX‐3 but not by the catalytically inactive ATX‐3C20S mutant (Figure 1c, Table S3).
Figure 1

Autophagy is impaired in atx‐3 deletion worms. (a) Survival rate upon refeeding of starved L1 larvae of the long‐lived strain cdc‐48.1(tm544); atx‐3(gk193) or the single‐deletion strains atx‐3(gk193) and cdc‐48.1(tm544) compared with wild‐type worms. (b) Starved L1 larvae of the atx‐3 deletion strains atx‐3(tm1689) and atx‐3(gk193) show decreased survival rate upon refeeding compared with wild‐type worms. (c) The decreased survival of the atx‐3(gk193) mutant strain can be rescued by introduction of GFP‐tagged wild‐type ATX‐3 protein but not the catalytic inactive mutant C20S. (d) Reduction in bec‐1 levels by RNAi further decreases the survival of atx‐3(gk193) mutant worms upon starvation. (e) Western blot analysis of autophagy protein LGG‐1 in total worm lysates of day 1 adult well‐fed worms or worms starved for 9 hr. Worms were treated with the lysosomal inhibitor chloroquine at the indicated concentration from L4 stage (performed in duplicates for treatment with 5 mM chloroquine). Immunoblotting was performed using anti‐GFP and anti‐tubulin antibodies. (f) Total worm lysates of mutant and wild‐type worms expressing Q40‐YFP aggregation‐prone protein in body‐wall muscle cells have been subjected to Western blot analysis. The Western blot shows the amounts of Q40::YFP and ATX‐3 protein in the PBS‐soluble (S) and PBS‐insoluble (pellet, P; only dissolved in SDS‐containing buffer) fraction of total worm lysates in WT, atx‐3(gk193), and cdc‐48.1(tm1544); atx‐3(gk193) mutants. Western blot analysis was done using anti‐GFP and anti‐ATX‐3 antibodies. (g) Quantification of relative band intensities of Q40‐YFP in soluble and pellet fraction was done. Data are presented as mean value and SD derived from two independent experiments. (h) Relative motility of indicated strains expressing aggregation‐prone Q40‐YFP protein in body‐wall muscle cells (Student's t test, unpaired, two‐tailed, n ≥ 20, *p ≤ .05, ***p ≤ .001)

Autophagy is impaired in atx‐3 deletion worms. (a) Survival rate upon refeeding of starved L1 larvae of the long‐lived strain cdc‐48.1(tm544); atx‐3(gk193) or the single‐deletion strains atx‐3(gk193) and cdc‐48.1(tm544) compared with wild‐type worms. (b) Starved L1 larvae of the atx‐3 deletion strains atx‐3(tm1689) and atx‐3(gk193) show decreased survival rate upon refeeding compared with wild‐type worms. (c) The decreased survival of the atx‐3(gk193) mutant strain can be rescued by introduction of GFP‐tagged wild‐type ATX‐3 protein but not the catalytic inactive mutant C20S. (d) Reduction in bec‐1 levels by RNAi further decreases the survival of atx‐3(gk193) mutant worms upon starvation. (e) Western blot analysis of autophagy protein LGG‐1 in total worm lysates of day 1 adult well‐fed worms or worms starved for 9 hr. Worms were treated with the lysosomal inhibitor chloroquine at the indicated concentration from L4 stage (performed in duplicates for treatment with 5 mM chloroquine). Immunoblotting was performed using anti‐GFP and anti‐tubulin antibodies. (f) Total worm lysates of mutant and wild‐type worms expressing Q40‐YFP aggregation‐prone protein in body‐wall muscle cells have been subjected to Western blot analysis. The Western blot shows the amounts of Q40::YFP and ATX‐3 protein in the PBS‐soluble (S) and PBS‐insoluble (pellet, P; only dissolved in SDS‐containing buffer) fraction of total worm lysates in WT, atx‐3(gk193), and cdc‐48.1(tm1544); atx‐3(gk193) mutants. Western blot analysis was done using anti‐GFP and anti‐ATX‐3 antibodies. (g) Quantification of relative band intensities of Q40‐YFP in soluble and pellet fraction was done. Data are presented as mean value and SD derived from two independent experiments. (h) Relative motility of indicated strains expressing aggregation‐prone Q40‐YFP protein in body‐wall muscle cells (Student's t test, unpaired, two‐tailed, n ≥ 20, *p ≤ .05, ***p ≤ .001) While autophagy promotes the survival of L1 larvae during starvation, its excessive activation or misregulation is not beneficial but rather increases the mortality of starving worms (Kang, You, & Avery, 2007). To analyze whether reduced or increased autophagy is accountable for the decreased survival of atx‐3 deletion worms, we curtailed autophagy through silencing of bec‐1, the worm orthologue of beclin‐1. We found that the partial depletion of bec‐1 did not rescue but further reduced the survival of the mutant worms, implying that the deletion of atx‐3 results in a reduced activity of autophagy (Figure 1d, Table S4). Moreover, it suggests that it reduces autophagy activity independent of the BEC‐1 complex, which was further supported by the observation that the levels of lipidated GFP‐LGG‐1, the nematode orthologue of LC3/GABARAP, remained unaffected upon deletion of ATX‐3 (Figure 1e). Similarly, we observed that the partial depletion of unc‐51, the nematode orthologue of ULK1, which is the upstream Ser/Thr protein kinase involved in the activation of autophagy in C. elegans, further aggravated the mortality of atx‐3 mutant worms (Figure S1A, Table S5). Another process that strongly depends on functional autophagy and that is of direct relevance for polyQ diseases is the clearance of aggregation‐prone proteins (Ravikumar et al., 2004). Both wild‐type and ATX‐3‐deficient worms developed visible inclusions upon muscle‐specific expression of an aggregation‐prone polyQ repeat (Morley, Brignull, Weyers, & Morimoto, 2002) (Figure S1B). Biochemical analysis showed an increase in SDS‐insoluble polyQ‐YFP aggregates in the atx‐3‐deficient strain that was comparable to the cdc‐48.1; atx‐3 double mutant, consistent with reduced clearance of protein aggregates (Figure 1f,g). PolyQ‐based aggregation in the muscle triggered reduced motility of atx‐3 and cdc‐48.1; atx‐3 mutant worms compared with wild‐type worms (Figure 1h). Combined, these data suggest a stimulatory role of ATX‐3 in autophagy in a multicellular organism relevant for the cellular stress response to starvation and protein aggregation.

ATXN3 depletion impairs autophagic degradation of long‐lived proteins and increases the number of autophagosomes

To explore whether human ATXN3 is involved in autophagy, we analyzed the autophagic flux directly by determining the fraction of long‐lived intracellular proteins that were either degraded by basal or starvation‐induced autophagy in control or ATXN3‐depleted cells. We used two different ATXN3‐specific siRNAs that both efficiently depleted ATXN3 (Figure 2a). Proteins were metabolically labeled, followed by a 16‐hr chase to allow degradation of short‐lived proteins. Degradation of long‐lived proteins during a 4‐hr starvation period was monitored by quantification of free radiolabeled amino acids (Klionsky et al., 2016). This analysis revealed that the depletion of ATXN3 with two independent siRNAs caused a significant reduction in degradation of long‐lived proteins in starved cells (Figure 2b), which corresponded to an estimated 20%–50% reduction in autophagic flux based on the difference in degradation of long‐lived proteins in control and ATXN3‐depleted cells during starvation compared with starvation in the presence of bafilomycin A1 (Figure 2c).
Figure 2

ATXN3 depletion increases the number of autophagosomes and impairs degradation of long‐lived proteins. (a) Knockdown efficiency of two different siRNAs targeting ATXN3 (ATXN3si #1, ATXN3si #2) in HOS GFP‐LC3 cells. (b) Long‐lived protein degradation assay in U2OS cells depleted of ATXN3 and treated as indicated. Percentage of long‐lived protein degradation was quantified. Data are presented as mean ± SD of three independent experiments, each performed in technical duplicates. *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA). (c) Percentage of long‐lived protein degradation by autophagy was quantified as the bafilomycin A1‐sensitive fraction of degradation during starvation in (b); *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA). (d) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3 using two different siRNAs (ATXN3si #1, ATXN3si #2). Cells were treated as indicated and imaged live using an automated widefield microscope. Scale bar: 20 μm. (e) Quantification of GFP‐LC3 puncta per cell upon ATXN3 depletion in HOS GFP‐LC3 cells. Data are presented as box plot with median and 5–95 percentile of at least two independent experiments, n ≥ 360, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test). (f) Representative micrographs of endogenous LC3B in wild‐type or ATXN3 knockout (KO) mouse embryonic fibroblasts (MEFs) treated as indicated for 4 hr. Scale bar: 20 μm (g) Western blot analysis of autophagy proteins in HOS GFP‐LC3 upon siRNA‐mediated depletion of ATXN3. Cells were treated as indicated for 4 hr and analyzed by immunoblotting using the indicated antibodies (s.e.: short exposure; l.e.: long exposure). (h) Quantification of GFP‐LC3 puncta per cell upon ATXN3 depletion using ATXN3si #2 and transient overexpression of mCherry‐C1 (mCh.), mCherry‐ATXN3 WT (WT), or mCherry‐ATXN3 C14A (C14A) in HOS GFP‐LC3 cells. Cells were starved for 4 hr in the presence of 100 nM bafilomycin A1. Data are presented as box plot with median and 5–95 percentile of four independent experiments, n ≥ 700, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test). (i) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3 using ATXN3si #2 and transfected with mCherry‐C1 (mCh.), mCherry‐ATXN3 WT (WT), or mCherry‐ATXN3 C14A (C14A). Cells were imaged live using an automated widefield microscope. Intensities in micrographs showing mCherry signal of WT and C14A samples were rescaled. Scale bar: 20 μm

ATXN3 depletion increases the number of autophagosomes and impairs degradation of long‐lived proteins. (a) Knockdown efficiency of two different siRNAs targeting ATXN3 (ATXN3si #1, ATXN3si #2) in HOS GFP‐LC3 cells. (b) Long‐lived protein degradation assay in U2OS cells depleted of ATXN3 and treated as indicated. Percentage of long‐lived protein degradation was quantified. Data are presented as mean ± SD of three independent experiments, each performed in technical duplicates. *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA). (c) Percentage of long‐lived protein degradation by autophagy was quantified as the bafilomycin A1‐sensitive fraction of degradation during starvation in (b); *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA). (d) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3 using two different siRNAs (ATXN3si #1, ATXN3si #2). Cells were treated as indicated and imaged live using an automated widefield microscope. Scale bar: 20 μm. (e) Quantification of GFP‐LC3 puncta per cell upon ATXN3 depletion in HOS GFP‐LC3 cells. Data are presented as box plot with median and 5–95 percentile of at least two independent experiments, n ≥ 360, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test). (f) Representative micrographs of endogenous LC3B in wild‐type or ATXN3 knockout (KO) mouse embryonic fibroblasts (MEFs) treated as indicated for 4 hr. Scale bar: 20 μm (g) Western blot analysis of autophagy proteins in HOS GFP‐LC3 upon siRNA‐mediated depletion of ATXN3. Cells were treated as indicated for 4 hr and analyzed by immunoblotting using the indicated antibodies (s.e.: short exposure; l.e.: long exposure). (h) Quantification of GFP‐LC3 puncta per cell upon ATXN3 depletion using ATXN3si #2 and transient overexpression of mCherry‐C1 (mCh.), mCherry‐ATXN3 WT (WT), or mCherry‐ATXN3 C14A (C14A) in HOS GFP‐LC3 cells. Cells were starved for 4 hr in the presence of 100 nM bafilomycin A1. Data are presented as box plot with median and 5–95 percentile of four independent experiments, n ≥ 700, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test). (i) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3 using ATXN3si #2 and transfected with mCherry‐C1 (mCh.), mCherry‐ATXN3 WT (WT), or mCherry‐ATXN3 C14A (C14A). Cells were imaged live using an automated widefield microscope. Intensities in micrographs showing mCherry signal of WT and C14A samples were rescaled. Scale bar: 20 μm GFP‐LC3 shows diffuse fluorescence under normal conditions but localizes to autophagosomes when autophagy is induced by nutrient starvation, which can be quantified by fluorescence microscopy analysis of the number of fluorescent puncta. Surprisingly, the depletion of ATXN3 with either siRNA resulted in a significant increase in GFP‐LC3 puncta when lysosomal degradation was blocked by bafilomycin A1 treatment under basal and nutrient‐starved conditions (Figure 2d,e). This increase suggests that more autophagic structures were formed in ATXN3‐depleted cells during the treatment. To validate this finding, we stained similarly treated wild‐type and ATXN3 knockout murine embryonic fibroblasts (Schmitt et al., 2007; Weishaupl et al., 2019) for endogenous LC3, which confirmed elevated levels of both basal and starvation‐induced LC3 puncta in ATXN3 knockout cells (Figure 2f, Figure S2A,B). No increase in LC3 foci was observed when ATXN3‐depleted cells were starved in the presence of the phosphatidylinositol‐3‐kinase (PI3K) inhibitor wortmannin, indicating that ATXN3 acts in the canonical autophagy–lysosome pathway downstream of PI3K (Figure 2e, Figure S2C). The increase in GFP‐LC3 puncta in ATXN3‐depleted cells was not accompanied by a detectable increase in the levels of lipidated GFP‐LC3 (Figure 2g) or endogenous lipidated LC3/GABARAP (Figure 2g, Figure S2D,E). This observation suggests that the accumulation of GFP‐LC3 puncta in ATXN3‐depleted cells does not reflect a change in the levels of autophagosome‐associated LC3. Despite its ability to increase the number of autophagosomes, the depletion of ATXN3 did not increase the autophagic flux as measured using double‐tagged mRFP‐GFP‐LC3 (Figure S3A). We, however, consistently detected increased mRFP and GFP intensities in ATXN3‐depleted samples during starvation, both in the presence or in the absence of bafilomycin A1 treatment compared with controls, confirming the increase in autophagosomes detected by microscopy (Figure S3B‐E). Notably, the levels of beclin‐1 were not altered in ATXN3‐depleted GFP‐LC3 HOS cells (Figure 2g), HeLa cells (Figure S2D), or U2OS cells (Figure S2E), excluding that effects on autophagy were caused by enhanced proteasomal degradation of beclin‐1, which has recently been identified as an ATXN3 substrate (Ashkenazi et al., 2017). The increase in GFP‐LC3 puncta upon ATXN3 depletion was rescued by transient overexpression of wild‐type but not catalytically inactive mCherry‐ATXN3, confirming that the observed effect is specific for ATXN3 (Figure 2h,i, Figure S4). Furthermore, in line with our observations in C. elegans, these data suggest that ATXN3 requires its DUB activity to support autophagy.

ATXN3 acts upstream of p97/VCP

The ATXN3 interactor p97/VCP, the human orthologue of CDC‐48, has been linked to the maturation of autophagosomes by a yet‐to‐be determined mechanism (Ju et al., 2009; Tresse et al., 2010). In order to assess whether the effect of ATXN3 is epistatic with p97/VCP depletion, we either depleted ATXN3, p97/VCP, or both simultaneously, and analyzed the accumulation of LC3 puncta. Despite the fact that both p97/VCP and ATXN3 depletion had a striking effect on the localization of GFP‐LC3 foci, the distribution pattern was rather different with a more perinuclear localization of LC3 in p97/VCP‐depleted cells (Figure 3a,b). The number of LC3 puncta was not affected upon p97/VCP depletion, in contrast to the significantly increased number of GFP‐LC3 puncta in ATXN3‐depleted cells (Figure 3b,c). In cells that had been co‐depleted of p97/VCP and ATXN3 (Figure 3a‐c), the number of GFP‐LC3 puncta as well as their distribution pattern was similar to what was observed when ATXN3 alone was depleted, suggesting that ATXN3 acts upstream of p97/VCP. These observations are in line with a stimulatory role of ATXN3 in autophagy through regulation of an event that precedes the maturation step stimulated by p97/VCP.
Figure 3

ATXN3 acts upstream of p97/VCP in the autophagy pathway. (a) Knockdown efficiencies of siRNA oligos targeting ATXN3 and/or p97/VCP after 48 hr. (b) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3, p97/VCP, or both using the indicated siRNAs. Cells were starved in the presence of 100 nM bafilomycin A1 for 4 hr. Scale bar: 20 μm. (c) Quantification of GFP‐LC3 puncta in (b). Data are shown as box plot with median and 5–95 percentile of two independent experiments, n > 1,200, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test)

ATXN3 acts upstream of p97/VCP in the autophagy pathway. (a) Knockdown efficiencies of siRNA oligos targeting ATXN3 and/or p97/VCP after 48 hr. (b) Representative micrographs of HOS GFP‐LC3 cells depleted of ATXN3, p97/VCP, or both using the indicated siRNAs. Cells were starved in the presence of 100 nM bafilomycin A1 for 4 hr. Scale bar: 20 μm. (c) Quantification of GFP‐LC3 puncta in (b). Data are shown as box plot with median and 5–95 percentile of two independent experiments, n > 1,200, *p ≤ .05, **p ≤ .01, ***p ≤ .001 (Kruskal–Wallis test)

ATXN3 interacts directly with GABARAP and LC3C

In light of its promiscuous interaction with various ubiquitin‐related proteins (Burnett, Li, & Pittman, 2003; Ferro et al., 2007; Pfeiffer et al., 2017), we wondered whether ATXN3 binds the autophagy receptors LC3 and GABARAP, which belong to the Atg8 family of ubiquitin‐like modifiers (Schaaf, Keulers, Vooijs, & Rouschop, 2016). To this end, we incubated recombinant ATXN3 with LC3A and GABARAP agarose beads, which revealed a robust interaction between ATXN3 and GABARAP, while binding of ATXN3 to LC3A was not observed (Figure 4a). Similar to recombinant ATXN3, we found that ectopically expressed ATXN3 with N‐terminal histidine (10xHis) and C‐terminal hemagglutinin (HA) epitope tags (10xHisATXN3HA) as well as endogenous ATXN3 binds GABARAP. Additionally, interaction with LC3A was also detected, albeit much less pronounced (Figure 4b). As an internal control, we validated that p62, a known Atg8‐interacting protein, was precipitated by the beads. The specificity of the ATXN3 signal was confirmed, as induction of 10xHisATXN3HA increased the amounts of ATXN3 in the GABARAP precipitates, while siRNA‐mediated depletion of ATXN3 resulted in a loss of the ATXN3 signal (Figure S5).
Figure 4

ATXN3 directly interacts with GABARAP and LC3C. (a) Purified, recombinant ATXN3 was incubated with blocked agarose beads (empty beads, e.b.) or recombinant GABARAP/LC3A immobilized on agarose beads. Binding was analyzed by immunoblotting. (b) Cell lysates from HeLa cells expressing doxycycline (dox)‐inducible 10xHisATXN3HA were incubated with blocked agarose beads (e.b.) or recombinant GABARAP/LC3A immobilized on agarose beads. Binding of endogenous ATXN3 and 10xHisATXN3HA was analyzed by immunoblotting with the indicated antibodies; * indicates band corresponding to ATXN3 from previous detection. (c) Cell lysates from HeLa cells expressing dox‐inducible 10xHisATXN3HA were incubated with purified, recombinant GST‐tagged Atg8 proteins and binding analyzed by immunoblotting with the indicated antibodies. (d) Schematic illustration of GFP‐ATXN3 constructs used in (e). (e) Cell lysates from HeLa cells transfected with the indicated constructs were incubated with blocked empty agarose beads (e.b.) or recombinant GABARAP immobilized on agarose beads. Binding was analyzed with immunoblotting using the indicated antibodies

ATXN3 directly interacts with GABARAP and LC3C. (a) Purified, recombinant ATXN3 was incubated with blocked agarose beads (empty beads, e.b.) or recombinant GABARAP/LC3A immobilized on agarose beads. Binding was analyzed by immunoblotting. (b) Cell lysates from HeLa cells expressing doxycycline (dox)‐inducible 10xHisATXN3HA were incubated with blocked agarose beads (e.b.) or recombinant GABARAP/LC3A immobilized on agarose beads. Binding of endogenous ATXN3 and 10xHisATXN3HA was analyzed by immunoblotting with the indicated antibodies; * indicates band corresponding to ATXN3 from previous detection. (c) Cell lysates from HeLa cells expressing dox‐inducible 10xHisATXN3HA were incubated with purified, recombinant GST‐tagged Atg8 proteins and binding analyzed by immunoblotting with the indicated antibodies. (d) Schematic illustration of GFP‐ATXN3 constructs used in (e). (e) Cell lysates from HeLa cells transfected with the indicated constructs were incubated with blocked empty agarose beads (e.b.) or recombinant GABARAP immobilized on agarose beads. Binding was analyzed with immunoblotting using the indicated antibodies As there are six Atg8 family members in mammalian cells, we next sought to characterize the specificity of ATXN3 for these proteins further. Lysates of HeLa 10xHisATXN3HA were incubated with GST‐LC3A, GST‐LC3B, GST‐LC3C, GST‐GABARAP, GST‐GABARAPL1, or GST‐GABARAPL2 immobilized on glutathione beads, and precipitates were analyzed for 10xHisATXN3HA. This approach confirmed that 10xHisATXN3HA precipitated with GST‐GABARAP and to a lesser extent with GST‐LC3A. Additionally, we detected strong binding of GST‐LC3C to 10xHisATXN3HA (Figure 4c). To define the domain in ATXN3 that is required for GABARAP binding, we generated a series of green fluorescent protein (GFP)‐tagged fragments of ATXN3 that were ectopically expressed in HeLa cells (Figure 4d). Incubation of the cell lysates with GABARAP‐coated beads revealed that the N‐terminal half of ATXN3, comprising the catalytic Josephin domain, interacted with GABARAP (Figure 4e). Further deconvolution showed that the interaction between the C‐terminal part of the Josephin domain and GABARAP was most pronounced with weaker binding of GABARAP to the N‐terminal part of the Josephin domain (Figure 4e). These results suggest that ATXN3 interacts with GABARAP, and likely LC3C, through multiple binding sites in its Josephin domain.

The Josephin domain contains two conserved LIR motifs

In silico analysis of the ATXN3 sequence (NP_004984.2), using iLIR (Kalvari et al., 2014), revealed the presence of six putative LIRs ([W/F/Y]‐x‐x‐[L/V/I]) with variable PSSM scores (Figure S6A,B). All putative LIRs were located in the Josephin domain, whereas no candidate LIRs were identified in the C‐terminal part of ATXN3. To identify the LIR(s) responsible for the GABARAP/LC3C interaction, we synthesized and spotted the N‐terminal sequence of ATXN3 (1–182), encompassing the Josephin domain, as 20‐mer peptides on cellulose membranes, and analyzed binding of GST‐tagged fusions of GABARAP and LC3C to the immobilized peptides (Figure 5a,b). LC3C bound to a LIR sequence located in the central part of the Josephin domain (FFSI, aa 74–77, LIR1), while both GABARAP and LC3C bound to peptides containing a LIR sequence located more toward the C‐terminal part of the Josephin domain (WFNL, aa130‐133, LIR2) (Figure 5b, Figure S6B). This observation may also provide an explanation for the observed binding of both halves of the Josephin domain to GABARAP as LIR1 and LIR2 are located in the N‐terminal and C‐terminal fragments of the Josephin domain, respectively. Both LIRs are highly conserved in ATXN3 orthologues among various species, suggesting a conserved function for these motifs (Figure 5c). We assessed the catalytic activity of ATXN3 mutants in which the critical residues in LIR1 or LIR2 or both had been mutated toward K63‐linked hexa‐ubiquitin chains in vitro and found that both mutations compromised the deubiquitylation activity of ATXN3 (Figure S6C). For the LIR1 mutant, this result was expected as this LIR motif shares a critical residue with the ubiquitin‐binding site 1 (UbS1; Ile77Glu78) in the ATXN3 Josephin domain. This site has recently been shown to be crucial for ATXN3 activity as it is required to position the ubiquitin C‐terminus for cleavage (Nicastro et al., 2010). LIR2 is located directly adjacent to Asp134, an essential residue of the catalytic triad of ATXN3, which may explain why mutating LIR2 renders ATXN3 inactive. Since the expression of an ATXN3 LIR2 mutant in mammalian cells and protein purification from bacteria turned out to be problematic with low expression and yields, we suspect that these mutations may also impair folding of the catalytic domain. Due to the lack of DUB activity of these mutants combined with the low expression levels, we have been unable to address the significance of these LIRs for the functional role of ATXN3 in autophagy.
Figure 5

The ATXN3 Josephin domain contains two conserved LIR motifs. (a) Schematic illustration of peptide spot assay to identify LIR motifs in the ATXN3 Josephin domain. The N‐terminal sequence of ATXN3 (1–182) was synthesized as 20‐mer peptides and spotted on cellulose membranes. (b) Binding of GST‐tagged fusions of GABARAP and LC3C to the spotted ATXN3 Josephin peptides was analyzed by immunoblotting. (c) Conservation of the identified LIR1 and LIR2 across species. (d) Catalytic activity of recombinant ATXN3 toward recombinant pre‐GABARAP‐GFP was analyzed in vitro by incubation of 250 ng pre‐GABARAP‐GFP with the indicated amounts of ATXN3 for 16 hr at 37°C. Recombinant His6‐Atg4B was used as control

The ATXN3 Josephin domain contains two conserved LIR motifs. (a) Schematic illustration of peptide spot assay to identify LIR motifs in the ATXN3 Josephin domain. The N‐terminal sequence of ATXN3 (1–182) was synthesized as 20‐mer peptides and spotted on cellulose membranes. (b) Binding of GST‐tagged fusions of GABARAP and LC3C to the spotted ATXN3 Josephin peptides was analyzed by immunoblotting. (c) Conservation of the identified LIR1 and LIR2 across species. (d) Catalytic activity of recombinant ATXN3 toward recombinant pre‐GABARAP‐GFP was analyzed in vitro by incubation of 250 ng pre‐GABARAP‐GFP with the indicated amounts of ATXN3 for 16 hr at 37°C. Recombinant His6‐Atg4B was used as control The specific interaction of the catalytic domain of ATXN3 with GABARAP and LC3C raised the question whether ATXN3 displays protease activity toward these ubiquitin‐like proteins. While the authentic protease of GABARAP, Atg4B (Tanida et al., 2004), readily cleaved a recombinant GABARAP‐GFP fusion protein, ATXN3 did not display any activity toward this fusion protein (Figure 5d).

ATXN3 localizes to autophagosomes

Based on the interactions identified above, we wondered whether ATXN3 localizes to autophagosomes. To this end, we analyzed the distribution of ATXN3 in HeLa cells under control conditions, when basal autophagy is active, and under nutrient starvation to stimulate autophagy. Epitope‐tagged 10xHisATXN3HA showed a diffuse staining in both the cytosol and nucleus, which remained unchanged during starvation (Figure 6a, Figure S7A). Next, we analyzed the localization of 10xHisATXN3HA in cells that overexpressed 3xMyc‐tagged ATG16L1 (3xMycATG16L1) as this is known to induce the formation of pre‐autophagosomal structures and stall their progression (Polson et al., 2010). As expected, this resulted in an increase in WIPI2‐positive puncta, a marker for early autophagosomes (Polson et al., 2010), which co‐localized with the ectopically overexpressed 3xMycATG16L1 (Figure S8). Notably, ATG6L1 overexpression resulted in the appearance of distinct ATXN3 puncta, which typically localized in close proximity to ATG16L1 structures under basal and starved conditions (Figure 6b, Figure S7B). Overexpression of GFP‐tagged LC3 also resulted in ATXN3 re‐localization to distinct puncta, where ATXN3 co‐localized with the GFP‐LC3 foci, consistent with translocation of ATXN3 to autophagosomes (Figure 6c).
Figure 6

ATXN3 localizes at autophagosomes. (a, b) HeLa cells expressing dox‐inducible 10xHisATXN3HA were transfected with empty vector (a) or 3xMycATG16L1 (b) and 10xHisATXN3HA expression induced for 24 hr. Cells were starved for 2 hr, fixed, and immunolabeled using antibodies against HA‐tag and Myc‐tag. Line scan at site of 3xMycATG16L1 accumulation to visualize the spatial distribution of the proteins. The percentage of 3xMycATG16L1 puncta that were associated with ATXN3 was quantified. Data are presented as mean ± SEM of four independent experiments. (c) HeLa cells expressing dox‐inducible 10xHisATXN3HA were transfected with GFP‐LC3 and 10xHisATXN3HA expression induced for 24 hr. Cells were starved for 2 hr, fixed, and immunolabeled using antibodies against HA. Line scan at site of GFP‐LC3 accumulation to visualize the spatial distribution of the proteins. The percentage of GFP‐LC3 puncta that co‐localized with ATXN3 was quantified. Data are presented as mean ± SEM of three independent experiments (d) HeLa cells were treated as indicated for 4 hr and cell lysates analyzed by immunoblotting using the indicated antibodies. (e) Band intensities were quantified and normalized to β‐actin and to the respective control treatment. Data are presented as mean ± SD of three independent experiments. *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA)

ATXN3 localizes at autophagosomes. (a, b) HeLa cells expressing dox‐inducible 10xHisATXN3HA were transfected with empty vector (a) or 3xMycATG16L1 (b) and 10xHisATXN3HA expression induced for 24 hr. Cells were starved for 2 hr, fixed, and immunolabeled using antibodies against HA‐tag and Myc‐tag. Line scan at site of 3xMycATG16L1 accumulation to visualize the spatial distribution of the proteins. The percentage of 3xMycATG16L1 puncta that were associated with ATXN3 was quantified. Data are presented as mean ± SEM of four independent experiments. (c) HeLa cells expressing dox‐inducible 10xHisATXN3HA were transfected with GFP‐LC3 and 10xHisATXN3HA expression induced for 24 hr. Cells were starved for 2 hr, fixed, and immunolabeled using antibodies against HA. Line scan at site of GFP‐LC3 accumulation to visualize the spatial distribution of the proteins. The percentage of GFP‐LC3 puncta that co‐localized with ATXN3 was quantified. Data are presented as mean ± SEM of three independent experiments (d) HeLa cells were treated as indicated for 4 hr and cell lysates analyzed by immunoblotting using the indicated antibodies. (e) Band intensities were quantified and normalized to β‐actin and to the respective control treatment. Data are presented as mean ± SD of three independent experiments. *p ≤ .05, **p ≤ .01, ***p ≤ .001 (one‐way ANOVA) The observation that ATXN3 localizes to autophagosomes upon ATG16L1 overexpression suggests that ATXN3 transiently interacts with early autophagosomal structures but does not progress through the autophagic pathway. This also implies that ATXN3 is not targeted for lysosomal degradation unlike other LC3/GABARAP‐interacting proteins, such as p62 (Pankiv et al., 2007). Consistent with this notion, inhibition of autophagy by 3‐methyladenine (3‐MA) or bafilomycin A1 in nutrient‐starved cells did not result in an increase in the steady‐state levels of ATXN3, whereas p62 was stabilized (Figure 6d,e). We conclude that ATXN3 is an LC3C/GABARAP‐interacting protein that is recruited to autophagosomes in a transient fashion, where it regulates their formation and stimulates the autophagic flux.

DISCUSSION

In this study, we identified ATXN3 as a GABARAP/LC3C‐interacting DUB that localizes to autophagosomes and revealed a novel regulatory function in autophagy. Surprisingly, we found that nematodes deficient for ATX‐3 and CDC‐48, which have an approximate 50% expansion of their lifespan, are hypersensitive to starvation conditions, resulting in reduced survival of food‐deprived mutant larvae. The starvation response required the catalytic activity of ATX‐3, while CDC‐48 deletion did not decrease viability of the worms in response to nutrient starvation. Since longevity is usually associated with increased autophagy (Leidal et al., 2018), it is striking that the extended lifespan of the cdc‐48.1; atx‐3 double mutant worms occurs at the expense of the ability to cope with prolonged starvation. Interestingly, atx‐3 mutant worms do not show increased sensitivity toward proteotoxic insults such as high temperature, oxidative stress, or bortezomib treatment (Kuhlbrodt et al., 2011; Rodrigues et al., 2007). Thus, the specific decrease in the survival of atx‐3 mutant worms under starvation stress is indicative of a specialized role of ATX‐3 in the fine‐tuning of autophagy to survive unfavorable environmental conditions. Our results are in striking contrast to the recent observation by Ashkenazi and coworkers, who identified the autophagy‐regulating factor beclin‐1 as a target for ATXN3 deubiquitylating activity and demonstrated polyQ‐mediated binding between beclin‐1/ATXN3. Stabilization of beclin‐1 by ATXN3 was proposed to explain the stimulatory role of ATXN3 on LC3 lipidation (Ashkenazi et al., 2017). Even though our data also argue for a stimulatory role of ATXN3 in autophagy, within the shorter time frame of ATXN3 depletion that we employed in this study, neither beclin‐1 levels nor LGG‐1/LC3 lipidation was reduced upon ATX‐3 or ATXN3 depletion. Moreover, the starvation sensitivity phenotype of atx‐3 deletion worms was aggravated by crippling autophagy (bec‐1 or unc‐51 depletion), suggesting a conserved beclin‐1‐independent role in autophagy and degradation of long‐lived proteins. It is also noteworthy that C. elegans ATX‐3 lacks the polyQ tract present in the human protein (Rodrigues et al., 2007), which shows that ATX‐3 is able to stimulate autophagy independent of a polyQ stretch and strongly argues in favor of a function different from the polyQ‐dependent regulation of beclin‐1. ATXN3 joined the arsenal of neurodegeneration‐associated proteins that have been found to promote various events in the autophagy–lysosome pathway (Deng et al., 2017; Wong & Cuervo, 2010). The shared commitment of these proteins to autophagy brings up important questions about the underlying pathophysiological mechanisms of these diseases, which are characterized by the accumulation of aggregation‐prone proteins. It is plausible that defects in protein degradation may contribute to disease manifestation. Interestingly, genetic tempering with autophagy in mice gives rise to neurodegenerative disorders with the presence of ubiquitin‐positive protein inclusions that are hallmarks of these diseases (Hara et al., 2006; Komatsu et al., 2006). With respect to ATXN3, the recent identification of Huntingtin, the polyQ protein responsible for Huntington's disease, as a substrate adaptor for autophagy, appears to be most relevant (Rui et al., 2015). A feature that ATXN3 shares with Huntingtin and other cargo receptors is the binding of both GABARAP/LC3 and ubiquitin conjugates. However, our data do not support a classical role of ATXN3 in substrate delivery since autophagy receptors typically join their substrates to the lysosomes and are degraded in the process. In contrast, we did not detect lysosomal degradation of ATXN3. Hence, the identified LIR motifs might be required for the recruitment of ATXN3 to autophagosomes in a more temporally controlled manner. Such a mechanism would not be unprecedented since similar targeting functions of LIR motifs have been described for other effector proteins in the autophagy pathway, including ULK1, ATG4B, and mitogen‐activated protein kinase 15 (MAPK15) (Alemu et al., 2012; Colecchia et al., 2012; Skytte Rasmussen et al., 2017). The functional significance of the two identified LIRs will require further exploration before definite conclusions can be drawn. Analysis of the published structures of the Josephin domain indicates that the LIR1 motif is partly exposed but will have to undergo a minor conformational change to align properly (Mao et al., 2005; Nicastro et al., 2005). Due to its proximity to the UbS1 site (Nicastro et al., 2010), occupancy of LIR1 with LC3C will likely hinder binding of ubiquitin and interfere with its DUB activity. The LIR2 motif, on the other hand, is buried within the Josephin domain and is of structural importance for the integrity of this domain. Exposure of the LIR2 motif to GABARAP/LC3C would therefore require a conformational change in the Josephin domain. While conformational changes upon substrate engagement are not uncommon in DUBs (Hu et al., 2002; Johnston, Riddle, Cohen, & Hill, 1999), a quite dramatic structural reorganization of the catalytic domain would be required to surface expose this LIR motif, making it unlikely, though not impossible, that it contributes to the interaction between LC3C/GABARAP and ATXN3. The fact that binding of LC3C/GABARAP to the LIR(s) may inhibit the catalytic activity of ATXN3, while at the same time the catalytic activity is required for its role in autophagy, is intriguing. One possibility is that there is a relay mechanism in play where ATXN3 is first recruited to autophagosomes by binding LC3C/GABARAP followed by the replacement of GABARAP/LC3C for a ubiquitylated substrate. This model could also explain the transient nature of its interaction with autophagosomes. Alternatively, the catalytic activity of ATXN3 may be required for processing substrates other than ubiquitin chains. While we did not detect any activity toward an artificial GABARAP precursor, this does not yet exclude the possibility that ATXN3 may process conjugates of GABARAP/LC3C or other Atg8 members. Counterintuitively, ATXN3 depletion increases the number of LC3 puncta without an accompanying increment in lipidated LC3. It is plausible that local inhibition of the formation of autophagosomes by ATXN3 may ensure that the available pool of lipidated LC3 is not diluted among an excessively large number of autophagosomes, which may otherwise hinder efficient autophagic clearance. This model would explain why ATXN3 only localizes to a subpopulation of ATG16L1‐positive structures and why ATXN3 is not degraded in the process despite its co‐localization with markers for autophagosomes. Thus, we propose that ATXN3 may localize to a subpopulation of ATG16L1 structures that will not further progress to the formation of autophagosomes due to the suppressive activity of ATXN3. Although speculative, these models provide us with a framework for further exploration of the molecular role of ATXN3 in autophagy. Together, we conclude that ATXN3 stimulates autophagy and thereby optimizes the cellular response to nutrient starvation and proteotoxic stress, two conditions that rely heavily on autophagy.

EXPERIMENTAL PROCEDURES

Starvation of worms

Worms were maintained at 20°C on NGM plates seeded with Escherichia coli (OP50). Gravid adult worms were washed off plates and treated with alkaline bleach (7.7 ml H2O + 2 ml 10% bleach + 0.3 ml 10 M NaOH) to isolate embryos. The isolated embryos were hatched in M9 buffer at 20°C without food overnight (ca. 10–50 eggs/μl). The arrested first‐stage larvae (L1) were incubated in M9 buffer, rotating at 20°C for the indicated number of days. To monitor starvation survival as the recovery rate upon refeeding, aliquots from each sample were taken every 1–3 days and plated on 3.5 cm NGM plates seeded with E. coli (OP50) for recovery. After 2 days of recovery at 20°C, surviving worms that had resumed growth and developed past the L1 larval stage were counted and removed. Plates were inspected after an additional 24 hr to count worms that developed slower and were missed in the first round of counting. The recovery rate observed on the first day of starvation (24 hr after egg isolation and incubation in M9 buffer) was set to 100% and recovery rates of the following days normalized to this.

Motility assay

Worms were grown on E. coli (OP50) bacteria at 20°C until day 1 adulthood (72 hr after L1 stage). Worms were transferred to a drop of M9 buffer, and after 30 s of adaptation, the number of body bends of n = 20 worms was counted for 30 s. A body bend was defined as change in direction of the bend at the mid‐body.

Long‐lived protein degradation

Reverse transfection of U2OS cells was done by dilution of siRNA oligonucleotides and Lipofectamine 2000 in DMEM + GlutaMAX. Cells were added at a density of 8.8 × 104 cells/ml in a final volume of 400 μl (final siRNA concentration: 40 nM). Cells were labeled by the addition of 0.125 μCi/ml L‐[14C] valine to the medium for 24 hr, followed by two washes and a 16‐hr chase in medium containing 10 mM nonradioactive l‐valine, to allow degradation of short‐lived proteins. Subsequently, cells were washed and subjected to the indicated treatments in medium containing 10 mM nonradioactive l‐valine for 4 hr. Radioactivity in the acid‐soluble and acid‐insoluble fractions was measured using Ultima Gold LSC cocktail (Perkin Elmer) and a liquid scintillation counter (Tri‐Carb 3100T Perkin Elmer).

Peptide scan

The N‐terminal sequence of human ATXN3 (aa 1–182; NP_004984.2) was synthesized as 20‐mer peptides with two amino acid offsets on cellulose membranes using a MultiPep automated peptide synthesizer (INTAVIS Bioanalytical Instruments) as described (Knaevelsrud et al., 2013). Peptide arrays were blocked in 1% casein in PBS‐T for 1 hr at RT. Overlays were done using 1 μg/ml GST‐fusion proteins or GST in 1% casein PBS‐T overnight at 4°C. Membranes were washed three times in PBS‐T and bound proteins detected by immunoblotting with anti‐GST‐HRP. See Supporting Information Experimental Procedures for all additional experimental procedures.

CONFLICT OF INTEREST

No competing interests declared.

AUTHOR CONTRIBUTIONS

LKH, EK, TH, and NPD designed the research; LKH, EK, RM, AHL, CB, CB, AP, and MEG performed the experiments; LKH, EK, RM, AHL, CB, FAS, AS, TH, and NPD analyzed the data; and LKH, EK, TH, and NPD wrote the manuscript. Click here for additional data file.
  53 in total

Review 1.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

2.  Loss of autophagy in the central nervous system causes neurodegeneration in mice.

Authors:  Masaaki Komatsu; Satoshi Waguri; Tomoki Chiba; Shigeo Murata; Jun-ichi Iwata; Isei Tanida; Takashi Ueno; Masato Koike; Yasuo Uchiyama; Eiki Kominami; Keiji Tanaka
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

3.  Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.

Authors:  John M Warrick; Lance M Morabito; Julide Bilen; Beth Gordesky-Gold; Lynn Z Faust; Henry L Paulson; Nancy M Bonini
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

4.  The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis.

Authors:  Kirsten Kuhlbrodt; Philipp Christoph Janiesch; Éva Kevei; Alexandra Segref; Roja Barikbin; Thorsten Hoppe
Journal:  Nat Cell Biol       Date:  2011-02-13       Impact factor: 28.824

5.  Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP.

Authors:  K Matthew Scaglione; Eszter Zavodszky; Sokol V Todi; Srikanth Patury; Ping Xu; Edgardo Rodríguez-Lebrón; Svetlana Fischer; John Konen; Ana Djarmati; Junmin Peng; Jason E Gestwicki; Henry L Paulson
Journal:  Mol Cell       Date:  2011-08-19       Impact factor: 17.970

Review 6.  Autophagy Receptors and Neurodegenerative Diseases.

Authors:  Zhiqiang Deng; Kerry Purtell; Veronik Lachance; Mitchell S Wold; Shi Chen; Zhenyu Yue
Journal:  Trends Cell Biol       Date:  2017-02-03       Impact factor: 20.808

7.  Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

Authors:  Min Hu; Pingwei Li; Muyang Li; Wenyu Li; Tingting Yao; Jia-Wei Wu; Wei Gu; Robert E Cohen; Yigong Shi
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

8.  Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3.

Authors:  Qiuyan Wang; Lianyun Li; Yihong Ye
Journal:  J Cell Biol       Date:  2006-09-25       Impact factor: 10.539

9.  Polyglutamine tracts regulate beclin 1-dependent autophagy.

Authors:  Avraham Ashkenazi; Carla F Bento; Thomas Ricketts; Mariella Vicinanza; Farah Siddiqi; Mariana Pavel; Ferdinando Squitieri; Maarten C Hardenberg; Sara Imarisio; Fiona M Menzies; David C Rubinsztein
Journal:  Nature       Date:  2017-04-26       Impact factor: 49.962

10.  Huntingtin functions as a scaffold for selective macroautophagy.

Authors:  Yan-Ning Rui; Zhen Xu; Bindi Patel; Zhihua Chen; Dongsheng Chen; Antonio Tito; Gabriela David; Yamin Sun; Erin F Stimming; Hugo J Bellen; Ana Maria Cuervo; Sheng Zhang
Journal:  Nat Cell Biol       Date:  2015-02-16       Impact factor: 28.824

View more
  18 in total

Review 1.  Deubiquitylating enzymes in neuronal health and disease.

Authors:  Fatima Amer-Sarsour; Alina Kordonsky; Yevgeny Berdichevsky; Gali Prag; Avraham Ashkenazi
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

2.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

3.  Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity.

Authors:  Yao Yao; Sungki Hong; Takayuki Ikeda; Hiroyuki Mori; Ormond A MacDougald; Shigeyuki Nada; Masato Okada; Ken Inoki
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

Review 4.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

5.  VCP/p97 regulates Beclin-1-dependent autophagy initiation.

Authors:  Sandra M Hill; Lidia Wrobel; Avraham Ashkenazi; Marian Fernandez-Estevez; Keith Tan; Roland W Bürli; David C Rubinsztein
Journal:  Nat Chem Biol       Date:  2021-01-28       Impact factor: 15.040

6.  n-Butylidenephthalide Modulates Autophagy to Ameliorate Neuropathological Progress of Spinocerebellar Ataxia Type 3 through mTOR Pathway.

Authors:  Jui-Hao Lee; Si-Yin Lin; Jen-Wei Liu; Shinn-Zong Lin; Horng-Jyh Harn; Tzyy-Wen Chiou
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

7.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

Review 8.  Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.

Authors:  Yu-Shuan Chen; Zhen-Xiang Hong; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

9.  JOSD1 promotes proliferation and chemoresistance of head and neck squamous cell carcinoma under the epigenetic regulation of BRD4.

Authors:  Chao Jing; Dandan Liu; Qingchuan Lai; Linqi Li; Mengqian Zhou; Beibei Ye; Yue Wu; Hong Li; Kai Yue; Yansheng Wu; Yuansheng Duan; Xudong Wang
Journal:  Cancer Cell Int       Date:  2021-07-14       Impact factor: 5.722

10.  Rotating magnetic field delays human umbilical vein endothelial cell aging and prolongs the lifespan of Caenorhabditis elegans.

Authors:  Jiangyao Xu; Kan Liu; Tingting Chen; Tianying Zhan; Zijun Ouyang; Yushu Wang; Wen Liu; Xiaoyun Zhang; Yang Sun; Gaixia Xu; Xiaomei Wang
Journal:  Aging (Albany NY)       Date:  2019-11-22       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.